BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 18375641)

  • 1. Two cases of valproic acid poisoning treated with L-carnitine.
    Chan YC; Tse ML; Lau FL
    Hum Exp Toxicol; 2007 Dec; 26(12):967-9. PubMed ID: 18375641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carnitine as an antidote for acute valproate toxicity in children.
    Russell S
    Curr Opin Pediatr; 2007 Apr; 19(2):206-10. PubMed ID: 17496767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnitine in the treatment of valproic acid-induced toxicity.
    Lheureux PE; Hantson P
    Clin Toxicol (Phila); 2009 Feb; 47(2):101-11. PubMed ID: 19280426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Haemodialysis, L-carnitine therapy and valproic acid overdose].
    Minville V; Roche Tissot C; Samii K
    Ann Fr Anesth Reanim; 2004 Apr; 23(4):357-60. PubMed ID: 15120780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA; Abdella MM
    Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of acute valproic acid poisoning treated successfully with L-carnitine.
    Papaseit E; Farré M; López MJ; Clemente C; Campodarve I
    Eur J Emerg Med; 2012 Feb; 19(1):57-8. PubMed ID: 22223129
    [No Abstract]   [Full Text] [Related]  

  • 7. L-carnitine for acute valproic acid overdose: a systematic review of published cases.
    Perrott J; Murphy NG; Zed PJ
    Ann Pharmacother; 2010; 44(7-8):1287-93. PubMed ID: 20587742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of hemoperfusion and L-carnitine management in valproic acid overdose.
    Jung J; Eo E; Ahn KO
    Am J Emerg Med; 2008 Mar; 26(3):388.e3-4. PubMed ID: 18358983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [L-carnitine in valproic acid-induced hyperammonemia].
    Martín-del Rincón JP; Llompart-Pou JA; Ferreruela M; Velasco J
    Med Intensiva; 2014 Mar; 38(2):124-5. PubMed ID: 23017629
    [No Abstract]   [Full Text] [Related]  

  • 10. Carnitine supplementation for valproate-related hyperammonemia to maintain therapeutic valproate level.
    Sonik P; Hilty DM; Rossaro L; Bourgeois JA
    J Clin Psychopharmacol; 2011 Oct; 31(5):680-2. PubMed ID: 21881462
    [No Abstract]   [Full Text] [Related]  

  • 11. Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?
    Lheureux PE; Penaloza A; Zahir S; Gris M
    Crit Care; 2005 Oct; 9(5):431-40. PubMed ID: 16277730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levocarnitine for the Treatment of Valproic Acid-Induced Hyperammonemic Encephalopathy in Children: The Experience of a Large, Tertiary Care Pediatric Hospital and a Poison Center.
    Glatstein M; Bonifacio Rino P; de Pinho S; Scolnik D; Pivko-Levi D; Hoyte C
    Am J Ther; 2019; 26(3):e344-e349. PubMed ID: 29232283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case files of the Children's Hospital of Michigan Regional Poison Control Center: the use of carnitine for the management of acute valproic acid toxicity.
    Katiyar A; Aaron C
    J Med Toxicol; 2007 Sep; 3(3):129-38. PubMed ID: 18072149
    [No Abstract]   [Full Text] [Related]  

  • 14. Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy.
    Mock CM; Schwetschenau KH
    Am J Health Syst Pharm; 2012 Jan; 69(1):35-9. PubMed ID: 22180549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Massive valproic acid overdose, a misleading case.
    Sikma MA; Mier JC; Meulenbelt J
    Am J Emerg Med; 2008 Jan; 26(1):110.e3-6. PubMed ID: 18082799
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacokinetics of biological tags in a case of acute valpromide self poisoning].
    Commandeur D; Danguy Des Deserts M; Giacardi C; Eyrieux S; Ould-Ahmed M; Drouillard I
    Ann Biol Clin (Paris); 2010; 68(2):234-8. PubMed ID: 20348051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical course of a three year-old girl after overdose of valproic acid].
    Blicher TM; Vestergaard ET; Dalhoff KP
    Ugeskr Laeger; 2012 Apr; 174(17):1165-6. PubMed ID: 22533937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Manoguerra AS; Erdman AR; Woolf AD; Chyka PA; Caravati EM; Scharman EJ; Booze LL; Christianson G; Nelson LS; Cobaugh DJ; Troutman WG;
    Clin Toxicol (Phila); 2008 Aug; 46(7):661-76. PubMed ID: 18608263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproic acid toxicity: overview and management.
    Sztajnkrycer MD
    J Toxicol Clin Toxicol; 2002; 40(6):789-801. PubMed ID: 12475192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproate-induced hyperammonemia in juvenile ceroid lipofuscinosis (Batten disease).
    Larsen EP; Ostergaard JR
    Seizure; 2014 Jun; 23(6):429-34. PubMed ID: 24647346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.